Clinical Trial Update: DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy [NA]

View source ↗

Summary

DART I is a Phase IV trial evaluating a triple-antiretroviral drug combination in HIV patients who have not previously received antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections, AIDS | NA | Status: COMPLETED